NCT03205098

Completed

Evaluation of Biological Markers of Mesenteric Ischemia Duri...

University Hospital, Clermont-Ferrand Source

Compare

Other study identifiers

Sponsor study identifier

CHU-340

Secondary identifiers

2015-A00470-49

OTHER · 2015-A00470-49

Study Type

observational

Actual enrollment (reported)

200

Locations

1 country

Sites

1

Timeline

Study Start

June 19, 2015

Actual (reported)

Primary Completion

June 30, 2015

Actual (reported)

Study Completion

September 30, 2016

Actual (reported)

Brief Summary

To assess the evolution of biological markers of mesenteric ischemia during ultratrail.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 200 participants
Study completion date: September 30, 2016
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
June 19, 2015
Actual (reported)
Primary Completion
June 30, 2015
Actual (reported)
Study Completion
September 30, 2016
Actual (reported)
First Submitted
June 21, 2017
Actual (reported)
First Posted
July 2, 2017
Actual (reported)

Last Updated: July 2, 2017
Status Verified: June 2017
Last Update Submitted: June 29, 2017

Conditions

Ultra-trail Participation

Keywords

biological markersmesenteric ischemiaultratrail

Outcome Measures

Primary Outcomes (1)

Assess biological markers of mesenteric ischemia (IFABP)
during ultratrail.
at day 1

Secondary Outcomes (1)

Relationship between digestive symptoms and biological markers (IFABP).
at day 1

Study Arms (1)

Runners

To assess the evolution of biological markers of mesenteric ischemia during ultratrail.

Biological: Blood analysis

Interventions

Blood analysisBiological

Blood test of biological markers of mesenteric ischemia

Runners

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

participants or populations are selected based on predefined criteria

You may qualify if:

Healthy Voluntary Subject

Sponsors & Collaborators

University Hospital, Clermont-Ferrand
Otherlead

Study Sites (1)

CHU de Clermont-Ferrand

Clermont-Ferrand, Auvergne, 63003, France

MeSH Terms

Conditions

Mesenteric Ischemia

Interventions

Hematologic Tests

Condition Hierarchy (Ancestors)

Intestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesPeritoneal DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Clinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Study Officials

Sébastien PERBET
University Hospital, Clermont-Ferrand
PRINCIPAL INVESTIGATOR

Enrollment

200 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: OTHER
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

June 21, 2017

First Posted

July 2, 2017

Study Start

June 19, 2015

Actual (reported)

NCT01307254

Association Between Non-alcoholic Fatty Liver Disease and Iron Status

Unknown

NCT00910260

Impact on UVB Narrow Band and UVA1 Therapy on Serum 25-hydroxyvitamin D Levels

Completed

NCT06730035

PRediction of Outcomes and PERsonalized Radiotherapy by Biomarkers and Functional Imaging

Not ApplicableActive Not Recruiting

NCT05550844

Emphysema and FLNA Mutation (E-FLNA)

Completed

NCT05953311

Neurological Blood-based Biomarkers and Cognitive Disorders in Critically Ill Survivors.

Unknown

NCT06346054

Molecular Assessment for Gastro-Esophageal Cancer

Not ApplicableRecruiting

Age \> 18 years

Written consent

Subject affiliated to Social Security

Medical certificate (mandatory to take part in the ultra-trail)

You may not qualify if:

Refusal to participate
Subject with legal protection (guardianship, trusteeship)

Contact the study team to confirm eligibility.

Primary Completion

June 30, 2015

Actual (reported)

Study Completion

September 30, 2016

Actual (reported)

Last Updated

July 2, 2017

Record last verified: 2017-06

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT03205098
Data provider: ClinicalTrials.gov
Source updated: 2017-07-02
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:33:12 UTC

Locations

FR(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (1)

Runners

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations